1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Heart Failure Drugs Market
2.2. Global Heart Failure Drugs Market, By By Drug Class, 2024 (US$ Million)
2.3. Global Heart Failure Drugs Market, By By Distribution Channel, 2024 (US$ Million)
2.4. Global Heart Failure Drugs Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024
4. Heart Failure Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Heart Failure Drugs Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Angiotensin-converting Enzyme (ACE) inhibitors
5.3.2. Angiotensin II Receptor Blockers (ARBs)
5.3.3. Beta Blockers
5.3.4. Others (diuretics, inotropes, aldosterone antagonists, digoxin, sinus node inhibitors)
6. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
7. North America Heart Failure Drugs Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
7.3. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
7.4.Heart Failure Drugs Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
7.4.1.1.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
7.4.1.2.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
7.4.1.3.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8. UK and European Union Heart Failure Drugs Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.3. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.Heart Failure Drugs Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.1.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.2.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.3.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.4.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.5.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
8.4.1.6.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9. Asia Pacific Heart Failure Drugs Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.3. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.Heart Failure Drugs Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.1.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.2.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.3.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.4.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.5.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
9.4.1.6.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
10. Latin America Heart Failure Drugs Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
10.3. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
10.4.Heart Failure Drugs Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
10.4.1.1.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
10.4.1.2.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
10.4.1.3.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
11. Middle East and Africa Heart Failure Drugs Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
11.3. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
11.4.Heart Failure Drugs Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
11.4.1.1.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
11.4.1.2.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Heart Failure Drugs Market: By By Drug Class, 2023-2033, USD (Million)
11.4.1.3.2. Heart Failure Drugs Market: By By Distribution Channel, 2023-2033, USD (Million)
12. Company Profile
12.1.
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Novartis AG
12.3. Amgen Inc.
12.4. AstraZeneca Plc.
12.5. Bayer AG
12.6. GlaxoSmithKline plc.
12.7. Pfizer Inc.
12.8. Gilead Sciences, Inc.
12.9. Teva Pharmaceutical Industries Ltd.
12.10. Johnson & Johnson Services, Inc.
12.11. Daiichi Sankyo Company, Limited
